Financier | Commitments |
---|---|
IDA Grant | 65.00 |
P173845
Active
Olivier Basenya , Ghulam Sayed
Republic of Burundi
April 3, 2020
(as of board presentation)
April 10, 2020
July 8, 2020
US$ 5.00 million
Ministère de la Santé Publique et de la Lutte contre le Sida
2020
US$ 65.00 million
N/A
Substantial
December 31, 2025
No
BANK APPROVED
December 14, 2023
Financier | Commitments |
---|---|
IDA Grant | 65.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 65.00 |
IBRD + IDA Commitment | 65.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 5.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Aug 6, 2020 | IDA-D6160 | Loan Disb | 794,136.20 |
Jan 19, 2021 | IDA-D6160 | Loan Disb | 546,686.20 |
Dec 30, 2020 | IDA-D6160 | Loan Disb | 57,841.03 |
Dec 22, 2021 | IDA-D9640 | Loan Commitment | 60,000,000.00 |
Apr 10, 2020 | IDA-D6160 | Loan Commitment | 5,000,000.00 |
Jul 31, 2024 | IDA-D9640 | Loan Disb | 114,932.00 |
Mar 7, 2024 | IDA-D9640 | Loan Disb | 202,662.97 |
Apr 23, 2024 | IDA-D9640 | Loan Disb | 1,071,288.00 |
Dec 18, 2023 | IDA-D9640 | Loan Disb | 450,508.88 |
Dec 22, 2023 | IDA-D9640 | Loan Disb | 894,016.00 |
Jul 29, 2024 | IDA-D9640 | Loan Disb | 1,872,414.10 |
May 1, 2024 | IDA-D9640 | Loan Disb | 617,314.80 |
May 10, 2024 | IDA-D9640 | Loan Disb | 330,364.72 |
Mar 5, 2024 | IDA-D9640 | Loan Disb | 200,503.12 |
Jun 28, 2024 | IDA-D9640 | Loan Disb | 1,915,377.90 |
May 9, 2024 | IDA-D9640 | Loan Disb | 1,491,213.50 |
Aug 18, 2023 | IDA-D9640 | Loan Disb | 3,993,839.00 |
Jul 12, 2023 | IDA-D9640 | Loan Disb | 491,326.00 |
Aug 21, 2023 | IDA-D9640 | Loan Disb | 272,100.00 |
Nov 10, 2023 | IDA-D9640 | Loan Disb | 4,248,618.00 |
Mar 21, 2023 | IDA-D9640 | Loan Disb | 43,443.95 |
Apr 3, 2023 | IDA-D6160 | Loan Disb | -20.63 |
Apr 3, 2023 | IDA-D6160 | Loan Disb | -848.56 |
Aug 29, 2023 | IDA-D9640 | Loan Disb | 10,611,216.00 |
Apr 3, 2023 | IDA-D6160 | Loan Cancel | 897.28 |
Mar 15, 2022 | IDA-D6160 | Loan Disb | -17,137.73 |
Jun 3, 2022 | IDA-D9640 | Loan Disb | 3,000,000.00 |
Jul 22, 2022 | IDA-D9640 | Loan Disb | 12,553.63 |
Jan 13, 2022 | IDA-D6160 | Loan Disb | 43,414.01 |
Jun 9, 2022 | IDA-D6160 | Loan Disb | 7,990.25 |
Dec 30, 2021 | IDA-D6160 | Loan Disb | 17,310.98 |
May 20, 2021 | IDA-D6160 | Loan Disb | -50,380.00 |
May 28, 2021 | IDA-D6160 | Loan Disb | 724.88 |
Jun 24, 2022 | IDA-D6160 | Loan Disb | 8,914.22 |
Jul 27, 2021 | IDA-D6160 | Loan Disb | -50,058.28 |
Sep 1, 2021 | IDA-D6160 | Loan Disb | 39,107.97 |
Dec 3, 2020 | IDA-D6160 | Loan Disb | 6,630.12 |
Feb 12, 2021 | IDA-D6160 | Loan Disb | 320,838.00 |
Sep 14, 2020 | IDA-D6160 | Loan Disb | 239,340.00 |
Sep 22, 2020 | IDA-D6160 | Loan Disb | 260,188.56 |
Sep 29, 2020 | IDA-D6160 | Loan Disb | 32,448.01 |
Aug 12, 2020 | IDA-D6160 | Loan Disb | 32,448.00 |
Aug 20, 2020 | IDA-D6160 | Loan Disb | 259,584.00 |
Oct 29, 2020 | IDA-D6160 | Loan Disb | 1,629.27 |
Dec 7, 2020 | IDA-D6160 | Loan Disb | 1,149,926.40 |
Nov 18, 2020 | IDA-D6160 | Loan Disb | 38,172.00 |
Feb 24, 2021 | IDA-D6160 | Loan Disb | 516,429.03 |
Jul 15, 2020 | IDA-D6160 | Loan Disb | 1,000,000.00 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Satisfactory | 2024-12-16 |
Monitoring and Evaluation | Satisfactory | 2024-12-16 |
Overall Implementation Progress (IP) | Satisfactory | 2024-12-16 |
Project Management | Satisfactory | 2024-12-16 |
Procurement | Moderately Satisfactory | 2024-12-16 |
Financial Management | Moderately Satisfactory | 2024-12-16 |
Progress towards achievement of PDO | Satisfactory | 2024-12-16 |
Monitoring and Evaluation | Satisfactory | 2024-12-16 |
Overall Implementation Progress (IP) | Satisfactory | 2024-12-16 |
Procurement | Moderately Satisfactory | 2024-12-16 |
Financial Management | Moderately Satisfactory | 2024-12-16 |
Project Management | Satisfactory | 2024-12-16 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: |
---|---|
Outcomes | |
Risk to Development Outcome | |
Bank Performance | |
Borrower Performance | |
Government Performance | |
Implementing Agency |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Suspected COVID-19 cases reported and investigated based on national guidelines | Value | 0.00 | 100.00 | 0.00 |
Date | March 23, 2020 | December 28, 2020 | ||
Comment |
Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents | Value | 0.00 | 12.00 | 0.00 |
Date | March 23, 2020 | December 28, 2020 | ||
Comment |
Acute healthcare facilities with isolation capacity | Value | 8.00 | 26.00 | 0.00 |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
Burundi adopted adopted personal and community non-pharmaceutical interventions | Value | No | Yes | |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
Burundi has activated its public health Emergency Operations Center or a coordination mechanism for COVID-19 | Value | No | Yes | |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Health staff trained in infection prevention and control per MOH-approved protocols | Value | 0.00 | 1958.00 | 0.00 |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
Designated laboratories with staff trained to conduct COVID-19 diagnosis | Value | 0.00 | 12.00 | 0.00 |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
Burundi has reported to have contextualized their risk communication and community engagement strategies | Value | No | Yes | |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
Burundi has prepared a referral system to care for COVID-19 patients | Value | No | Yes | |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
For the first 10 suspected cases, percentage of laboratory results available within 72 hours | Value | 0.00 | 100.00 | 0.00 |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |
Individuals reached with tailored information | Value | 0.00 | 6500000.00 | 0.00 |
Date | March 31, 2020 | December 28, 2020 | ||
Comment |